Artemis Investment Management LLP acquired a new position in Monsanto Co. (NYSE:MON) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 149,363 shares of the company’s stock, valued at approximately $15,459,000.
Several other hedge funds have also recently bought and sold shares of the company. TIAA CREF Investment Management LLC increased its stake in Monsanto by 34.0% in the first quarter. TIAA CREF Investment Management LLC now owns 3,097,818 shares of the company’s stock worth $271,803,000 after buying an additional 786,058 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. increased its stake in Monsanto by 472.2% in the first quarter. Los Angeles Capital Management & Equity Research Inc. now owns 144,058 shares of the company’s stock worth $12,640,000 after buying an additional 118,881 shares in the last quarter. CQS Cayman LP increased its stake in Monsanto by 73.7% in the first quarter. CQS Cayman LP now owns 73,749 shares of the company’s stock worth $6,471,000 after buying an additional 31,294 shares in the last quarter. Mondrian Investment Partners LTD purchased a new stake in Monsanto during the first quarter worth approximately $56,462,000. Finally, Exane Asset Management purchased a new stake in Monsanto during the first quarter worth approximately $8,563,000. 79.06% of the stock is currently owned by institutional investors.
Monsanto Co. (NYSE:MON) traded up 0.12% during trading on Tuesday, hitting $102.25. The company had a trading volume of 3,109,860 shares. The stock has a market capitalization of $44.74 billion, a PE ratio of 45.00 and a beta of 1.24. Monsanto Co. has a one year low of $83.73 and a one year high of $114.26. The stock has a 50-day moving average of $105.47 and a 200-day moving average of $100.91.
Monsanto (NYSE:MON) last posted its earnings results on Wednesday, June 29th. The company reported $2.17 earnings per share for the quarter, missing analysts’ consensus estimates of $2.40 by $0.23. The company had revenue of $4.19 billion for the quarter, compared to the consensus estimate of $4.49 billion. Monsanto had a return on equity of 37.98% and a net margin of 7.76%. The business’s quarterly revenue was down 8.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.39 EPS. On average, equities analysts anticipate that Monsanto Co. will post $4.46 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be paid a dividend of $0.54 per share. The ex-dividend date of this dividend is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.11%. Monsanto’s payout ratio is presently 89.26%.
A number of research firms have recently commented on MON. Deutsche Bank AG reissued a “buy” rating and issued a $100.00 price objective on shares of Monsanto in a research note on Wednesday, June 1st. Vetr downgraded Monsanto from a “strong-buy” rating to a “buy” rating and set a $117.33 price objective on the stock. in a research note on Monday, May 30th. Piper Jaffray Cos. restated an “overweight” rating and issued a $127.00 target price (up from $95.00) on shares of Monsanto in a report on Monday, June 13th. Zacks Investment Research upgraded Monsanto from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 6th. Finally, Jefferies Group restated a “buy” rating on shares of Monsanto in a report on Tuesday, September 6th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $114.31.
In other Monsanto news, COO Brett D. Begemann sold 27,980 shares of the business’s stock in a transaction on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the sale, the chief operating officer now owns 102,480 shares of the company’s stock, valued at $10,618,977.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Michael K. Stern sold 12,797 shares of the business’s stock in a transaction on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the sale, the chief executive officer now directly owns 21,583 shares in the company, valued at approximately $2,196,501.91. The disclosure for this sale can be found here. Company insiders own 0.88% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Co. (NYSE:MON).
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.